Arthur He Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Arthur He

Stock Analyst at HC Wainwright & Co.

(5)
# 82
Out of 5,470 analysts
90
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
12 Stocks
Name Action PT Current % Upside Ratings Updated
ADAG Adagene
Maintains: Buy
8 7
2.31 203.03% 11 Aug 15, 2025
LVTX LAVA Therapeutics
Maintains: Neutral
2 2
1.55 -20% 11 Aug 5, 2025
AUPH Aurinia Pharmaceutic...
Assumes: Buy
17
12.43 36.77% 1 Jul 30, 2025
ADAP Adaptimmune Therapeu...
Downgrades: Neutral
n/a
n/a n/a 7 Jul 29, 2025
NKTR Nektar Therapeutics
Maintains: Strong Buy
7 120
40.48 196.44% 4 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.38 271.75% 10 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
75 85
24.45 247.65% 2 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 8 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 8 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 9
9.5 -5.26% 17 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
39
40 -2.5% 4 May 28, 2024